From Scientific Breakthrough to Funded Biotech Company
From Interesting Science → Investable Company
From Risky Experiments → Regulatory-Aligned Development
From Risky Experiments → Regulatory-Aligned Development
Investor Readiness & Fundraising Positioning
We transform complex science into a compelling investment story and prepare you to engage the right VCs with confidence.
From Risky Experiments → Regulatory-Aligned Development
From Risky Experiments → Regulatory-Aligned Development
From Risky Experiments → Regulatory-Aligned Development
Preclinical & IND Strategy
- We design preclinical plans that support future regulatory filings — not just publications.
- We manage your CRO ecosystem so timelines, quality, and budgets stay under control.
From International Team → U.S.-Ready Biotech
From Risky Experiments → Regulatory-Aligned Development
From International Team → U.S.-Ready Biotech
U.S. Market Entry & Company Setup
We guide international founders through the strategic and operational decisions needed to succeed in the U.S. ecosystem.
Guiding Founders Through Strategic Decisions
Some of our business development support includes:
Early-stage biotech business support
· Strategic estimation of startup costs for the first two years
· Detailed financial modeling for lab space acquisition, and operational expenses
· Support with U.S. market entry planning and operational setup
U.S. market entry planning for startups & Financial planning
· Coordination with legal partners to establish the required legal and compliance infrastructure for U.S.-based startups
· Development of compelling confidential and non-confidential investor decks
· Identification and targeting of venture capital firms specializing in pre-seed and seed-stage investments
Therapeutic area landscape analysis
· In-depth evaluation of external innovation opportunities across emerging platforms such as:
o Cell therapies
o Antibodies
o Gene therapies
· Scientific landscape analysis and innovation scouting
· Opportunity mapping across key therapeutic areas: oncology, immunology, CNS, and autoinmune diseases
Giving founders strategic confidence
ZCC Consulting partners with biotech founders to turn complex science into investor-ready, regulatory-aligned companies — faster, smarter & with less risk-
We don’t just advise. We design and execute your roadmap from idea to investment.
What Our Clients Really Gain
Not just strategy — but:
· Confidence in every major decision
· Faster progress with less wasted capital
· Stronger credibility with investors and partners
ZCC Consulting is built for:
· Biotech founders preparing for pre-seed, seed, or Series A
· Academic spinouts moving from lab to company
· International teams entering the U.S. market
· Platform biotech startups defining first clinical programs